TY - JOUR AU - Kristensen, L. S. AU - Hansen, T. B. AU - Veno, M. T. AU - Kjems, J. PY - 2018 DA - 2018// TI - Circular RNAs in cancer: opportunities and challenges in the field JO - Oncogene VL - 37 UR - https://doi.org/10.1038/onc.2017.361 DO - 10.1038/onc.2017.361 ID - Kristensen2018 ER - TY - JOUR AU - Xu, Z. AU - Yan, Y. AU - Zeng, S. AU - Dai, S. AU - Chen, X. AU - Wei, J. AU - Gong, Z. PY - 2018 DA - 2018// TI - Circular RNAs: clinical relevance in cancer JO - Oncotarget VL - 9 ID - Xu2018 ER - TY - JOUR AU - Shuwen, H. AU - Qing, Z. AU - Yan, Z. AU - Xi, Y. PY - 2018 DA - 2018// TI - Competitive endogenous RNA in colorectal cancer: a systematic review JO - Gene VL - 645 UR - https://doi.org/10.1016/j.gene.2017.12.036 DO - 10.1016/j.gene.2017.12.036 ID - Shuwen2018 ER - TY - JOUR AU - Liu, Y. C. AU - Li, J. R. AU - Sun, C. H. AU - Andrews, E. AU - Chao, R. F. AU - Lin, F. M. AU - Weng, S. L. AU - Hsu, S. D. AU - Huang, C. C. AU - Cheng, C. PY - 2016 DA - 2016// TI - CircNet: a database of circular RNAs derived from transcriptome sequencing data JO - Nucleic Acids Res VL - 44 UR - https://doi.org/10.1093/nar/gkv940 DO - 10.1093/nar/gkv940 ID - Liu2016 ER - TY - JOUR AU - Ingham, M. AU - Schwartz, G. K. PY - 2017 DA - 2017// TI - Cell-cycle therapeutics come of age JO - J Clin Oncol VL - 35 UR - https://doi.org/10.1200/JCO.2016.69.0032 DO - 10.1200/JCO.2016.69.0032 ID - Ingham2017 ER - TY - JOUR AU - Kalu, N. N. AU - Johnson, F. M. PY - 2017 DA - 2017// TI - Do CDK4/6 inhibitors have potential as targeted therapeutics for squamous cell cancers? JO - Expert Opin Investig Drugs VL - 26 UR - https://doi.org/10.1080/13543784.2017.1274731 DO - 10.1080/13543784.2017.1274731 ID - Kalu2017 ER - TY - JOUR AU - DiPippo, A. J. AU - Patel, N. K. AU - Barnett, C. M. PY - 2016 DA - 2016// TI - Cyclin-Dependent kinase inhibitors for the treatment of breast cancer: past, present, and future JO - Pharmacotherapy VL - 36 UR - https://doi.org/10.1002/phar.1756 DO - 10.1002/phar.1756 ID - DiPippo2016 ER - TY - JOUR AU - Wander, S. A. AU - Mayer, E. L. AU - Burstein, H. J. PY - 2017 DA - 2017// TI - Blocking the cycle: cyclin-dependent kinase 4/6 inhibitors in metastatic, hormone receptor-positive breast cancer JO - J Clin Oncol VL - 35 UR - https://doi.org/10.1200/JCO.2017.73.9482 DO - 10.1200/JCO.2017.73.9482 ID - Wander2017 ER - TY - JOUR AU - Bauzon, F. AU - Zhu, L. PY - 2010 DA - 2010// TI - Racing to block tumorigenesis after pRb loss: an innocuous point mutation wins with synthetic lethality JO - Cell Cycle VL - 9 UR - https://doi.org/10.4161/cc.9.11.11726 DO - 10.4161/cc.9.11.11726 ID - Bauzon2010 ER - TY - JOUR AU - Paternot, S. AU - Bockstaele, L. AU - Bisteau, X. AU - Kooken, H. AU - Coulonval, K. AU - Roger, P. P. PY - 2010 DA - 2010// TI - Rb inactivation in cell cycle and cancer: the puzzle of highly regulated activating phosphorylation of CDK4 versus constitutively active CDK-activating kinase JO - Cell Cycle VL - 9 UR - https://doi.org/10.4161/cc.9.4.10611 DO - 10.4161/cc.9.4.10611 ID - Paternot2010 ER - TY - JOUR AU - Popov, N. AU - Gil, J. PY - 2010 DA - 2010// TI - Epigenetic regulation of the INK4b–ARF–INK4a locus: in sickness and in health JO - Epigenetics VL - 5 UR - https://doi.org/10.4161/epi.5.8.12996 DO - 10.4161/epi.5.8.12996 ID - Popov2010 ER - TY - JOUR AU - Che, Y. AU - Ye, F. AU - Xu, R. AU - Qing, H. AU - Wang, X. AU - Yin, F. AU - Cui, M. AU - Burstein, D. AU - Jiang, B. AU - Zhang, D. Y. PY - 2012 DA - 2012// TI - Co-expression of XIAP and cyclin D1 complex correlates with a poor prognosis in patients with hepatocellular carcinoma JO - Am J Pathol VL - 180 UR - https://doi.org/10.1016/j.ajpath.2012.01.016 DO - 10.1016/j.ajpath.2012.01.016 ID - Che2012 ER - TY - JOUR AU - Sun, L. AU - Quan, H. AU - Xie, C. AU - Wang, L. AU - Hu, Y. AU - Lou, L. PY - 2014 DA - 2014// TI - Phosphodiesterase 3/4 inhibitor zardaverine exhibits potent and selective antitumor activity against hepatocellular carcinoma both in vitro and in vivo independently of phosphodiesterase inhibition JO - PLoS ONE VL - 9 UR - https://doi.org/10.1371/journal.pone.0090627 DO - 10.1371/journal.pone.0090627 ID - Sun2014 ER - TY - JOUR AU - O’Leary, B. AU - Finn, R. S. AU - Turner, N. C. PY - 2016 DA - 2016// TI - Treating cancer with selective CDK4/6 inhibitors JO - Nat Rev Clin Oncol VL - 13 UR - https://doi.org/10.1038/nrclinonc.2016.26 DO - 10.1038/nrclinonc.2016.26 ID - O’Leary2016 ER - TY - JOUR AU - Sherr, C. J. AU - Beach, D. AU - Shapiro, G. I. PY - 2016 DA - 2016// TI - Targeting CDK4 and CDK6: from discovery to therapy JO - Cancer Discov VL - 6 UR - https://doi.org/10.1158/2159-8290.CD-15-0894 DO - 10.1158/2159-8290.CD-15-0894 ID - Sherr2016 ER - TY - JOUR AU - Bustos, M. A. AU - Ono, S. AU - Marzese, D. M. AU - Oyama, T. AU - Iida, Y. AU - Cheung, G. AU - Nelson, N. AU - Hsu, S. C. AU - Yu, Q. AU - Hoon, D. S. B. PY - 2017 DA - 2017// TI - MiR-200a regulates CDK4/6 inhibitor effect by targeting CDK6 in metastatic melanoma JO - J Invest Dermatol VL - 137 UR - https://doi.org/10.1016/j.jid.2017.03.039 DO - 10.1016/j.jid.2017.03.039 ID - Bustos2017 ER -